Follow Us
Epaper Saturday, April 20, 2024

Chandigarh

New technology use in heart attack treatment brings down need of stents: experts

August 13, 2022 11:46 AM

Chandigarh: “A remarkable development in the treatment of heart attack patient has come up with the application of a new technology in many patients as cardiologists may not need to implant a stent,"

 

Dr.(Prof). Antonio Colombo, Professor of cardiology and senior consultant at Humanitas University in Milan who was recently at Medanta Hospital , Gurugram said that this device features a drug delivery technology platform coated onto the balloon designed to deliver sub-micron particles of sirolimus that are then encapsulated in a biocompatible drug carrier.

 

He further said the drug and carrier complex is designed to reach the inner layers of the vessel walls and act as a reservoir for the long-term release of sirolimus. Sirolimus is a medicine that prevents re-narrowing of the coronary artery & is backed by huge data for safety & long-term efficacy, he opined.

 

Dr. Rajneesh Kapoor, vice chairman of interventional cardiology at Medanta Hospital said, "To prevent re-narrowing of arteries, in patients where implanting a stent is not best suited or needs to be avoided, interventional cardiology practice approves treating the patient with the use of a new medical device known as the Sirolimus drug-coated balloon catheter,”

 

“Theoretically, stent-free angioplasty might be superior to angioplasty using a stent since it may prevent long-term issues of dual antiplatelet therapy like medicines to prevent blood clot), stent fracture, and stent thrombosis which is formation of a blood clot around the stent,” said Dr Kapoor .


He said that we are happy with the use of this technology use and find it of massive utility in the Indian scenario because of the alarming rise of coronary artery disease, especially in the young ones in whom we desire treating with minimum changes to natural vessel layout, so that they have to take least possible medicines for long & have least treatment related risk such as In-Stent restenosis which is a blockage or narrowing that comes back in the portion of the coronary artery previously treated with a stent, maintained Dr Kapoor.

 

Have something to say? Post your comment